Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX

Lineage Therap (LCTX) Financial Statements

1,806 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently ―. The company's EPS TTM is $-0.134; its P/E ratio is -7.57; Lineage Therap is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.44M$ 2.09M$ 1.20M$ 3.20M$ 2.40M
Gross Profit$ 1.35M$ 1.83M$ 1.03M$ 3.10M$ 2.27M
EBIT$ -6.56M$ -6.36M$ -7.59M$ -5.58M$ -6.21M
EBITDA$ -6.38M$ -6.19M-$ -5.42M$ -6.04M
Net Income Common Stockholders$ -6.54M$ -4.78M$ -7.11M$ -5.23M$ 13.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 43.62M$ 35.49M$ 41.37M$ 45.92M$ 46.81M
Total Assets$ 108.48M$ 101.02M$ 106.15M$ 111.69M$ 113.00M
Total Debt$ 3.25M$ 2.95M$ 3.08M$ 3.40M$ 3.64M
Net Debt$ -40.37M$ -32.54M$ -38.29M$ -42.52M$ -43.18M
Total Liabilities$ 37.49M$ 39.00M$ 39.49M$ 40.43M$ 44.19M
Stockholders Equity$ 72.40M$ 63.42M$ 68.12M$ 72.67M$ 70.45M
Cash Flow-
Free Cash Flow$ -5.82M$ -6.11M-$ -6.52M$ -11.43M
Operating Cash Flow$ -5.78M$ -6.02M$ -5.04M$ -6.27M$ -11.24M
Investing Cash Flow$ -38.00K$ 9.74M$ 2.12M$ 19.16M$ 15.43M
Financing Cash Flow$ 14.02M$ -13.00K$ 807.00K$ 5.63M$ 1.00K
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis